Merck & Co., Inc. Chief Medical Officer to Discuss the Future of Innovation at Biotech 2011

TRENTON, N.J. & WAYNE, Pa.--(BUSINESS WIRE)--The barriers to innovation in the life sciences – and potential solutions – will be examined by Michael Rosenblatt, M.D., executive vice president and chief medical officer at Merck in a luncheon keynote address on October 24 at Biotech 2011.

MORE ON THIS TOPIC